254 related articles for article (PubMed ID: 31651571)
21. Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects.
Zhang S; Du T; Li M; Jia J; Lu H; Lin X; Yu X
Medicine (Baltimore); 2017 Jun; 96(22):e7041. PubMed ID: 28562560
[TBL] [Abstract][Full Text] [Related]
22. Special Population: Lean Nonalcoholic Fatty Liver Disease.
Duseja A; De A; Wong V
Clin Liver Dis; 2023 May; 27(2):451-469. PubMed ID: 37024218
[TBL] [Abstract][Full Text] [Related]
23. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in lean NAFLD.
Xu R; Pan J; Zhou W; Ji G; Dang Y
Biomed Pharmacother; 2022 Sep; 153():113331. PubMed ID: 35779422
[TBL] [Abstract][Full Text] [Related]
25. Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis.
Tang A; Ng CH; Phang PH; Chan KE; Chin YH; Fu CE; Zeng RW; Xiao J; Tan DJH; Quek J; Lim WH; Mak LY; Wang JW; Chew NWS; Syn N; Huang DQ; Siddiqui MS; Sanyal A; Muthiah M; Noureddin M
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1750-1760.e12. PubMed ID: 35863685
[TBL] [Abstract][Full Text] [Related]
26. Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: a prospective cohort study.
Zou Y; Yu M; Sheng G
Lipids Health Dis; 2020 Jun; 19(1):145. PubMed ID: 32563249
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.
Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
J Clin Gastroenterol; 2006 Sep; 40(8):745-52. PubMed ID: 16940890
[TBL] [Abstract][Full Text] [Related]
28. Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals.
Chan KE; Koh TJL; Tang ASP; Quek J; Yong JN; Tay P; Tan DJH; Lim WH; Lin SY; Huang D; Chan M; Khoo CM; Chew NWS; Kaewdech A; Chamroonkul N; Dan YY; Noureddin M; Muthiah M; Eslam M; Ng CH
J Clin Endocrinol Metab; 2022 Aug; 107(9):2691-2700. PubMed ID: 35587339
[TBL] [Abstract][Full Text] [Related]
29. Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis.
Wongtrakul W; Charatcharoenwitthaya N; Charatcharoenwitthaya P
Ann Hepatol; 2024; 29(3):101288. PubMed ID: 38278181
[TBL] [Abstract][Full Text] [Related]
30. Nonalcoholic fatty liver disease is associated with breast cancer in nonobese women.
Kwak MS; Yim JY; Yi A; Chung GE; Yang JI; Kim D; Kim JS; Noh DY
Dig Liver Dis; 2019 Jul; 51(7):1030-1035. PubMed ID: 30686716
[TBL] [Abstract][Full Text] [Related]
31. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients.
Sookoian S; Pirola CJ
Aliment Pharmacol Ther; 2017 Jul; 46(2):85-95. PubMed ID: 28464369
[TBL] [Abstract][Full Text] [Related]
32. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcomes in lean and non-lean NAFLD patients: a systematic review and meta-analysis.
Huang S; Bao Y; Zhang N; Niu R; Tian L
Endocrine; 2023 May; ():. PubMed ID: 37253855
[TBL] [Abstract][Full Text] [Related]
34. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
Li XD; Qiu BH; Su FC; Sun SX
Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
[TBL] [Abstract][Full Text] [Related]
35. Relationship between obstructive sleep apnea and nonalcoholic fatty liver disease in nonobese adults.
Qi JC; Huang JC; Lin QC; Zhao JM; Lin X; Chen LD; Huang JF; Chen X
Sleep Breath; 2016 May; 20(2):529-35. PubMed ID: 26174847
[TBL] [Abstract][Full Text] [Related]
36. Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals.
Yamada G; Hagiwara Y; Kimura T; Takeuchi Y; Oba K; Masuda K; Matsuyama Y
Am J Gastroenterol; 2021 Apr; 116(4):733-740. PubMed ID: 33982943
[TBL] [Abstract][Full Text] [Related]
37. Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity.
Sinha N; Mukhopadhyay S; Sau M
Indian J Gastroenterol; 2020 Feb; 39(1):75-83. PubMed ID: 32314167
[TBL] [Abstract][Full Text] [Related]
38. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.
Sookoian S; Pirola CJ
Aliment Pharmacol Ther; 2018 Jan; 47(1):16-25. PubMed ID: 29083036
[TBL] [Abstract][Full Text] [Related]
39. Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index.
Tobari M; Hashimoto E
Gut Liver; 2020 Sep; 14(5):537-545. PubMed ID: 31887811
[TBL] [Abstract][Full Text] [Related]
40. Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis.
Huang JF; Tsai PC; Yeh ML; Huang CF; Huang CI; Hsieh MH; Dai CY; Yang JF; Chen SC; Yu ML; Chuang WL; Chang WY
J Formos Med Assoc; 2020 Jan; 119(1 Pt 1):89-96. PubMed ID: 30952479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
